Smartphone Facial Scans May Be Able to Identify Anatomical Contributors to Sleep Disorders
Research shows how AI-based facial geometry analysis on smartphones could lead to more accessible and personalized treatments for insomnia and sleep apnea.
Category: Emerging Technology
Emerging Technology
Latest
Emerging Technology
Latest
Lucid Dreaming Research Lab Launches in Silicon Valley
Researchers at the facility aim to develop technologies for studying lucid dreaming and REM sleep phenomena.
Emerging Technology
Latest
NovaResp AI-Enabled CPAP Gets Closer to Launch After $2M Seed Plus Round
A $2m funding round will accelerate the company's product development and regulatory and precommercialization efforts as it prepares for a 2024 entry into the North American CPAP market.
Investigational Orexin-2 Receptor Agonist Improves Wakefulness in Narcolepsy Type 2 and IH
Alkermes plc announced positive results from a phase 1b study evaluating ALKS 2680 for treating narcolepsy type 2 and idiopathic hypersomnia.
Read More
New Tech Uses Magnetic Frequencies to Optimize Sleep Stages
Research involving 67 subjects who participated in over 7,772 sleep sessions demonstrated that 73% experienced notable improvements in their sleep, with enhancements in the depth and overall quality of sleep noted.
Read MoreLucid Dreamer Controls Smart Home Devices in Sleep
Researchers tested technology that allows people to control a smart home from lucid dreams. As a result, these people completed some typical morning actions before even waking up.
Read More
$12M Fuels Development of Wearable That Guides Brainwaves to Induce Sleep
The platform uses neurotechnology to read individual brainwaves and guide them in real time by responding with tailored stimulation.
Read More
Patent Awarded for Neuromodulation Tech to Treat ‘Coronasomnia’
The patent covers a novel method of facilitating a normal sleep cycle in a subject during a pandemic or peri-COVID vaccination period.
Read More
Under-the-Bed Magnetic Generator May Improve Deep Sleep, Study Finds
A study demonstrated improvements in deep sleep using the Soltec System, which consists of a non-invasive magnetic generator placed under the bed or near the footboard.
Read More
Nyxoah Sets Key Milestones for 2024, Aims to Replicate Its European Success Stateside
Nyxoah’s CEO says the company is on the cusp of “the most significant milestone” in its history.
Read MoreSwallowable Capsule Can Detect Sleep Apnea from the Stomach
Researchers have developed an ingestible capsule to non-invasively diagnose sleep apnea by monitoring vital signs from within the gastrointestinal tract.
Read More
Wearable Device Aids in Detecting Apneas in Premature Infants
Researchers have developed miniaturized wearable devices that continuously and wirelessly monitor sounds inside patients’ bodies, which could offer a new tool for detecting and analyzing apneas in premature infants.
Read More
New Sleep Line Promises Better Rest Through AI
A Dongguan, China-based sleep technology brand launched a new smart sleep line of artificial intelligence (AI)-powered mattresses, pillows, and beds.
Read More
Nyxoah and ResMed Germany Unite for Comprehensive Sleep Apnea Care
Nyxoah SA has partnered with ResMed Germany to increase OSA awareness and therapy penetration in the German market.
Read More
Could Ventilatory Burden Replace AHI in Sleep Apnea?
Mount Sinai’s newly developed ventilatory burden offers a potentially more effective alternative to the traditional AHI in assessing severity in sleep apnea patients.
Read MoreMusic from Lucid Dreams Recorded for Playback
Researchers from the California-based startup REMspace have achieved the real-time transmission of melodies from lucid dreams using electromyography sensors.
Read More
Nyxoah Speeds Pre-Commercialization as Neurostimulator Trial Progresses
Nyxoah announced operating results for the second quarter and first half of 2023, emphasizing advances in its investigational device exemption trial designed to support the marketing authorization of the Genio neurostimulator system for the treatment of OSA.
Read More
Nyxoah Highlights Positive Early Findings from Neurostimulator Trial for Sleep Apnea
The company has completed all 115 implants in the DREAM trial and expects full 12-month data in the first quarter of next year.
Read More